References
- Coldest G. A., Willett W. C. Menopause and the risk of coronary heart disease in women. N. Engl J Med 1987; 316: 1105–10
- Sullivan J. M., Vander Zwahh R., Hughes F. P., et al. Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women. Arch Intern Med 1990; 150: 2557–62
- Perrone G., Stefanutti C., Galoppi P., et al. Effect of oral and transdermal hormone replacement therapy on lipid profile and Lp(a) level in menopausal women with hypercholesterolemia. Int J Fertil Menopausal Stud 1996; 41: 509–15
- Thorn T. J. (1988) Cardiovascular disease mortality among United States women. Coronary Heart Disease in Women. Proceedings of an NIH Workshop. 1988, E.D. Eaker, B. Packard, et al. Haymarket Doyma, New York, 33–41
- van der Graaf Y., de Kleijn MJJ, van der Schouw Y. T. Menopause and cardiovascular disease. J Psychosom Obstet Gynecol. 1997; 18: 113–20
- Lipid, Research Clinics' Program. The Lipid Research Clinics Coronary Primary Trial Results: II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. J Am Med Assoc 1984; 251: 365–74
- Sack M. N., Rader D. J., Cannon R. O. Estrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet. 1994; 343: 269–70
- Lindoff C., Petersson F., Lecander I., et al. Transdermal estrogen replacement therapy: beneficial effects on haemostatic risk factors for cardiovascular disease. Maturitas 1996; 24: 43–50
- Stevenson J. C., Proudler A. J., Walton C., et al. HRT mechanisms of action: carbohydrates. Int J Fertil 1994; 39(Suppll)50–5
- Collins P., Rosano GMC, Jiang C., et al. Cardiovascular protection by estrogen - a calcium antagonist effect?. Lancet 1993; 341: 1264–5
- Bush T. L., Barrett-Connor E., Cowan L. D., et al. Cardiovascular mortality and non-contraceptive estrogen use in women: results from the Lipid Research Clinics' Program Follow-up Study. Circulation 1987; 75: 1002–9
- Samsioe G., Åstedt B. (1996) Does progestogen co-medication attenuate the cardiovascular benefits of estrogen?. Menopause: European Consensus Development Conference. 1996, H.B. Martin, R. Henri. Montreux, Switzerland, 175–84
- Hong M. K., Romm P. A., Reagen K., et al. Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women. Am J Cardiol 1992; 69: 176–8
- Stampfer M., Colditz G. Estrogen replacement therapy: a quantitative assessment of the epidemiologic evidence. rev Med 1991; 20: 47–63
- Denke M. A. Effects of continuous combined hormone replacement therapy on lipid levels in hypercholesterolemic postmenopausal women. Am J Med. 1995; 99: 29–35
- Tonstad S., Ose L., Gorbitz C., et al. Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolemia among postmenopausal women./. Int Med 1995; 238: 39–47
- Mattsson LÅ, Samsioe G., von Schoultz B., et al. Transdermally administered estradiol combined with oral medroxyprogesterone acetate: the effects on lipoprotein metabolism in postmenopausal women. BrJ Obstet Gynaecol 1993; 100: 450–3
- Ylä-Herttuala S., Luorha J., Kallionpaa H., et al. Pathogenesis of atherosclerosis. Maturitas 1996; 23(Suppl)47–9
- Godsland I. (1996) Anti-atherosclerotic effects of estrogen. Menopause. European Consensus Development Conference. 1996, H.B. Martin, R. Henri. Montreux, Switzerland, 161–9
- Rosano GMC, Sarrel P. M., Poole-Wilson P. A., et al. Beneficial effect of estrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet 1993; 342: 133–6
- Gilligan D. M., Badar D. M., Panza J A, et al. Acute vascular effects of estrogen in postmenopausal women. Circulation 1994; 90: 786–91
- Barrect-Connor E. Postmenopausal estrogen and prevention bias. Ann Int Med. 1991; 115: 455–6
- Matthews K. A., Kuller L. H., Wing R. R., et al. Prior to use of estrogen replacement therapy, are users healthier than non-users?. Am J Epidemiol 1996; 15(143)971–8